Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum

Finula I. Isik; Russell Pickford; Michelle Chua; Simon J.G. Lewis; Nicolas Dzamko; Woojin S. Kim

doi:10.1002/mds.70264

March 10, 2026Movement Disorders

Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum

View at Publisher

Ask AI

Bookmark

Share

Key Points

To investigate the levels of stearoyl-coenzyme A desaturase and monounsaturated fatty acids in Parkinson's disease serum and their implications for disease pathology.
Analysis of serum samples for SCD levels
Measurement of monounsaturated fatty acid content
Comparison with control groups
Elevated levels of stearoyl-coenzyme A desaturase were found in Parkinson's disease serum.
Increased concentrations of monounsaturated fatty acids were observed.
Findings suggest a link to altered membrane and sphingolipid metabolism in Parkinson's disease.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Reveals altered lipid metabolism in Parkinson's disease, suggesting new biomarker potential.

Abstract

Increased SCD and MUFA-enriched lipids indicate altered membrane and sphingolipid metabolism in PD, consistent with central disease pathology, that present a potential for novel biomarker development for PD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Isik et al. (2026) studied this question.

synapsesocial.com/papers/69b3ace502a1e69014ccef3e https://doi.org/10.1002/mds.70264

View at Publisher

Ask AI

Bookmark

Share

Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Elevation of Stearoyl‐Coenzyme A Desaturase and Monounsaturated Fatty Acids in Parkinson's Disease Serum

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading